Committed to innovative surgical solutions
Committed to innovative surgical solutions
Date: Friday, May 1, 2026
Time: 6:30 AM – 7:45 AM – Registration & Breakfast begin at 6:15 am
Room: 613 – 614
Location: Seattle, Washington – Seattle Convention Center
This scientific symposium, featuring leading breast cancer surgeons, will highlight the latest clinical data on breast-conserving surgery (BCS) combined with post-lumpectomy radiofrequency ablation (RFA) and its impact on reducing the need for adjuvant radiation therapy (RT).
Recent evidence demonstrates that intraoperative RFA applied to the lumpectomy cavity can create an additional circumferential tumor-free margin, significantly decreasing close or positive margins and lowering re-excision rates. Emerging long-term data also suggest that, in carefully selected patient populations, BCS + RFA may maintain local control while reducing—or potentially eliminating—the need for whole-breast radiation.
The symposium will review updated outcomes data, comparative analyses with other intraoperative technologies such as cryoablation and IORT, and real-world case studies utilizing a next-generation RFA probe specifically engineered for optimized energy delivery within the lumpectomy cavity.
• Review emerging long-term clinical data on BCS + RFA
• Understand margin optimization with intraoperative RFA
• Evaluate feasibility of radiation de-escalation strategies
• Compare intraoperative technologies including cryoablation and IORT
• Engage with leading breast cancer surgeons
Chief, Division of Breast Surgery & Breast Surgical Oncology Director, Breast Cancer Services Professor of Surgery, Montefiore Einstein
Dr. Sheldon Feldman is a leading breast surgical oncologist with extensive experience in minimally invasive breast surgery, oncoplastic techniques, and intraoperative radiation therapy. He serves as Chief of Breast Surgery & Breast Surgical Oncology and Director of Breast Cancer Services at Montefiore Einstein, where he is also Professor of Surgery. A past President of the American Society of Breast Surgeons, Dr. Feldman is recognized for his commitment to advancing breast cancer care, surgical innovation, and patient-centered treatment.
Adjunct Professor, Dept. of Surgery, Medical Director of UTMB Cancer Center, Adjunct Professor, MD Anderson Cancer Center, Houston
Dr. V. Suzanne Klimberg has 27 years of experience in breast surgical oncology. She has pioneered innovative breast cancer treatment methods, authored over 245 publications in peer-reviewed journals and edited 10 books and holds 8 patents, and has held over 25 editorial board positions for surgical journals and publications. Additionally, Dr. Klimberg has won over 75 awards in teaching, research, and surgery, and is the past president of three major American surgical organizations.
Professor of Surgery, NYU Langone Grossman School of Medicine Director of Surgical Quality and Innovation, Perlmutter Cancer Center
Dr. Jill Dietz is a nationally recognized breast surgeon and leader in surgical oncology. She completed her fellowship in breast surgical oncology and general surgery residency at Cleveland Clinic and earned her Master’s in Healthcare Management from Harvard T.H. Chan School of Public Health.
Dr. Dietz currently serves as the past President and Chairman of the Board of the American Society of Breast Surgeons. She co-leads Global Breast Hub and advises Breast Global—both committed to addressing disparities in breast cancer care globally.
Her clinical and research interests include oncoplastic surgery, value-based care, patient-centered surgical techniques, and innovations in breast cancer care delivery.
Be part of an important discussion shaping the future of breast cancer treatment. Learn from experts, examine new clinical data, and explore the potential of intraoperative ablation techniques in reducing the need for radiation in low-risk cases.
This symposium/program is supported by Innoblative Designs through a marketing grant. It is not part of the official American Society of Breast Surgeons annual meeting program, and no AMA PRA Category 1 Credits™ have been assigned to them by the ASBrS.
